|
GB1555654A
(en)
*
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
US4065562A
(en)
*
|
1975-12-29 |
1977-12-27 |
Nippon Shinyaku Co., Ltd. |
Method and composition for reducing blood glucose levels
|
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
GB2020278B
(en)
*
|
1978-05-03 |
1983-02-23 |
Nippon Shinyaku Co Ltd |
Moranoline dervitives
|
|
JPS568318A
(en)
|
1979-06-28 |
1981-01-28 |
Janssen Pharmaceutica Nv |
Non oral long acting composition of haloperidol and bromperidol derivative
|
|
GB8311286D0
(en)
|
1983-04-26 |
1983-06-02 |
Searle & Co |
Carboxyalkyl peptide derivatives
|
|
EP0144290A3
(de)
|
1983-12-01 |
1987-05-27 |
Ciba-Geigy Ag |
Substituierte Aethylendiaminderivate
|
|
US5041441A
(en)
*
|
1988-04-04 |
1991-08-20 |
The Regents Of The University Of Michigan |
Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
|
|
JPH0416856A
(ja)
|
1990-05-10 |
1992-01-21 |
Canon Inc |
正帯電性非磁性トナー
|
|
US5302609A
(en)
*
|
1992-12-16 |
1994-04-12 |
The Regents Of The University Of Michigan |
Treatment of diabetic nephropathy
|
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
WO1995005177A1
(en)
*
|
1993-08-13 |
1995-02-23 |
Seikagaku Corporation |
Remedy for nervous diseases
|
|
PT742789E
(pt)
*
|
1994-02-02 |
2000-12-29 |
Liposome Co Inc |
Lipossomas e compostos farmaceuticamente activos e metodos para a sua utilizacao
|
|
DE69524592T2
(de)
|
1994-06-10 |
2002-07-18 |
Seikagaku Corp., Tokio/Tokyo |
2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
|
|
WO1997010817A1
(en)
*
|
1995-09-20 |
1997-03-27 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6255336B1
(en)
*
|
1995-09-20 |
2001-07-03 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20030073680A1
(en)
*
|
1995-09-20 |
2003-04-17 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
WO2001004108A1
(en)
|
1999-07-09 |
2001-01-18 |
Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
NO965193L
(no)
*
|
1995-12-08 |
1997-06-09 |
Seikagaku Kogyo Kk Seikagaku C |
Aminalkoholderivat og fremgangsmåte for fremstilling derav
|
|
JP3993908B2
(ja)
|
1995-12-08 |
2007-10-17 |
生化学工業株式会社 |
アミノアルコール誘導体及び該誘導体の製造方法
|
|
JP4140984B2
(ja)
|
1995-12-20 |
2008-08-27 |
生化学工業株式会社 |
分化誘導作用を有する薬剤
|
|
US5972928A
(en)
*
|
1997-05-21 |
1999-10-26 |
Johns Hopkins University |
Methods for treatment of conditions associated with lactosylceramide
|
|
JP4036500B2
(ja)
|
1997-05-23 |
2008-01-23 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
JP4176170B2
(ja)
|
1997-06-06 |
2008-11-05 |
生化学工業株式会社 |
アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬
|
|
US6222619B1
(en)
*
|
1997-09-18 |
2001-04-24 |
University Of Utah Research Foundation |
Diagnostic device and method
|
|
US6465488B1
(en)
*
|
1997-12-11 |
2002-10-15 |
Chancellor, Masters & Scholars Of The University Of Oxford |
Inhibition of glycolipid biosynthesis
|
|
ES2285852T3
(es)
*
|
1998-07-27 |
2007-11-16 |
Johns Hopkins University |
Compuestos de diamino-propanol para el tratamiento de la isquemia.
|
|
US6610703B1
(en)
*
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB0100889D0
(en)
*
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
EP1384719A1
(en)
|
1999-07-09 |
2004-01-28 |
The Regents of The University of Michigan |
Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections
|
|
MXPA02000296A
(es)
*
|
1999-07-09 |
2004-05-21 |
Univ Michigan |
Compuestos parecidos a aminoceramida y metodos de uso.
|
|
US6407064B2
(en)
|
1999-12-06 |
2002-06-18 |
Seikagaku Corporation |
Aminoalcohol derivative and medicament comprising the same
|
|
JP5009459B2
(ja)
|
1999-12-06 |
2012-08-22 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
US6235737B1
(en)
*
|
2000-01-25 |
2001-05-22 |
Peter Styczynski |
Reduction of hair growth
|
|
CA2406067A1
(en)
|
2000-04-19 |
2001-11-01 |
Thomas Julius Borody |
Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
|
|
CA2432908A1
(en)
|
2000-12-20 |
2002-06-27 |
Bristol-Myers Squibb Pharma Company |
Diamines as modulators of chemokine receptor activity
|
|
WO2002053528A1
(en)
|
2000-12-29 |
2002-07-11 |
Wyeth |
Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
|
|
CA2434028C
(en)
|
2001-01-10 |
2010-11-09 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20020198240A1
(en)
*
|
2001-01-10 |
2002-12-26 |
Shayman James A. |
Amino ceramide - like compounds and therapeutic methods of use
|
|
US7148251B2
(en)
*
|
2001-01-10 |
2006-12-12 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20040260099A1
(en)
*
|
2001-01-10 |
2004-12-23 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
DK2266968T3
(da)
*
|
2001-07-16 |
2013-04-08 |
Genzyme Corp |
Syntese af UDP-glucose: N-acylsphingosin-glucosyltransferase-hæmmere
|
|
US6835831B2
(en)
*
|
2001-11-26 |
2004-12-28 |
Genzyme Corporation |
Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
|
|
GB0229931D0
(en)
*
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
JPWO2003057874A1
(ja)
|
2001-12-28 |
2005-05-19 |
住友製薬株式会社 |
腎疾患の疾患マーカー及びその利用
|
|
HRP20040660B1
(hr)
|
2002-01-22 |
2012-10-31 |
Warner-Lambert Company Llc |
2-(PIRIDIN-2-ILAMINO)-PIRIDO[2,3-d]PIRIMIDIN-7-ONI
|
|
EP1336411A1
(en)
|
2002-02-14 |
2003-08-20 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
|
|
JP2003238410A
(ja)
|
2002-02-21 |
2003-08-27 |
Seibutsu Yuki Kagaku Kenkyusho:Kk |
インスリン抵抗性解除剤
|
|
US6916802B2
(en)
*
|
2002-04-29 |
2005-07-12 |
Genzyme Corporation |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20060217560A1
(en)
*
|
2002-04-29 |
2006-09-28 |
Shayman James A |
Amino ceramide-like compounds and therapeutic methods of use
|
|
WO2004006756A2
(en)
|
2002-07-17 |
2004-01-22 |
Biogen Idec Ma Inc. |
THERAPIES FOR RENAL FAILURE USING INTERFERON-β
|
|
WO2004007453A1
(en)
|
2002-07-17 |
2004-01-22 |
Oxford Glycosciences (Uk) Ltd |
Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
|
|
WO2004078194A1
(en)
|
2003-02-28 |
2004-09-16 |
Intermune, Inc. |
Interferon drug therapy for the treatment of viral diseases and liver fibrosis
|
|
GB0313678D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
AU2004283631A1
(en)
|
2003-10-29 |
2005-05-06 |
Genzyme Corporation |
Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
|
|
EP1528056A1
(en)
*
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
JP2007516294A
(ja)
|
2003-12-23 |
2007-06-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
炎症性の疾患または症状の予防および治療のための方法および組成物
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
EP1576894A1
(en)
*
|
2004-03-16 |
2005-09-21 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and Metabolic Syndrome
|
|
DE602005026785D1
(de)
*
|
2004-03-16 |
2011-04-21 |
Tno |
Verwendung von sphingolipiden bei der behandlung und vorbeugung von typ-2-diabetes mellitus, insulinresistenz und metabolismussyndrom
|
|
AU2005240714B2
(en)
|
2004-05-07 |
2011-07-07 |
Merck Patent Gmbh |
GM3 synthase as a therapeutic target in microvascular complications of diabetes
|
|
WO2005123055A2
(en)
|
2004-06-14 |
2005-12-29 |
Musc Foundation For Research Development |
Methods for treating inflammatory disorders
|
|
CA2581173A1
(en)
*
|
2004-08-20 |
2006-03-02 |
The Johns Hopkins University |
Methods for treatment of angiogenesis
|
|
WO2006053043A2
(en)
|
2004-11-10 |
2006-05-18 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
|
HUE028654T2
(en)
|
2005-01-26 |
2016-12-28 |
Allergan Inc |
3-aryl-3-hydroxy-2-aminopropionic amides, 3-heteroaryl-3-hydroxy-2-aminopropionic amides and related compounds having analgesic and / or immunostimulating activity
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
PT2032134E
(pt)
|
2006-05-09 |
2015-10-07 |
Genzyme Corp |
Métodos de tratamento da doença do fígado gorduroso
|
|
WO2008011478A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
WO2008011487A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
CA2677485A1
(en)
|
2007-02-09 |
2008-08-14 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
EP2594565B1
(en)
|
2007-05-31 |
2018-10-24 |
Genzyme Corporation |
2-acylaminopropanol-type glucosylceramide synthase inhibitors
|
|
ES2660690T3
(es)
|
2007-10-05 |
2018-03-23 |
Genzyme Corporation |
Método para tratar poliquistosis renales con derivados de ceramida
|
|
WO2009117150A2
(en)
|
2008-03-20 |
2009-09-24 |
Genzyme Corporation |
Method of treating lupus with ceramide derivatives
|
|
JP2011529500A
(ja)
|
2008-07-28 |
2011-12-08 |
ジェンザイム コーポレーション |
虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害
|
|
CA2738768C
(en)
|
2008-10-03 |
2017-10-31 |
Genzyme Corporation |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
|